MagnaBioSciences, LLC (MBS) develops and manufactures immuno-diagnostic products based on its patented MICT (Magnet Immuno-Chromatographic Test) technology. The MICT system uses Superparamagnetic particles (SPMPs) as reporter elements and provides quantitative and precise measurements (comparable to laboratory chemistry analyzers) for a wide range of analytes.
The MICT diagnostic instrument and TSH test received FDA clearance under Section 510(k) on March 19, 2012. MBS' 2014 pipeline products include Progesterone and Prolactin, TSH, Free T4, hCG, LH, and FSH. Other available CE-marked products include cTnI, CK-MB, and Myoglobin.
MBS is actively seeking distributors worldwide.Link to further Information